Latest News for: icl

Edit

Listing of Secured Redeemable Non-Convertible Debentures of ICL Fincorp Limited (BSE Ltd)

Public Technologies 23 Feb 2026
Subject Listing of Secured Redeemable Non-Convertible Debentures of ICL Fincorp Limited ... The financial year of ICL Fincorp Limited ends on 31st March.<_o3a_p> ... · At ICL Fincorp Limited.<_o3a_p>.
Edit

Fourth Quarter 2025 Transcript (ICL Group Ltd)

Public Technologies 20 Feb 2026
ICL Group Ltd NYSE.ICL ... Good morning, ladies and gentlemen, and welcome to the ICL Fourth Quarter 2025 Earnings International Conference Call ... I'm Peggy Reilly Tharp, Vice President of Global Investor Relations for ICL Group ... ICL Group Ltd.
Edit

ICL Reports Fourth Quarter and Full Year 2025 Results

The Milton Standard Journal 18 Feb 2026
TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--Feb 18, 2026-- ....
Edit

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift ...

Business Wire 18 Feb 2026
... of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the U.S.
Edit

ICL Group: Q4 Earnings Snapshot

Gainesville Daily Register 18 Feb 2026
TEL AVIV, Israel (AP) — TEL AVIV, Israel (AP) — ICL Group Ltd (ICL) on Wednesday reported a loss of $73 million in its fourth quarter ....
Edit

Current Report by Foreign Issuer (Form 6-K) (ICL Group Ltd)

Public Technologies 18 Feb 2026
). The text version of this document is not available ... ICL Group Ltd.
Edit

Q4 2025 Results Presentation (ICL Group Ltd)

Public Technologies 18 Feb 2026
). The text version of this document is not available ... ICL Group Ltd.
Edit

Dividend Distribution Announcement (ICL Group Ltd)

Public Technologies 18 Feb 2026
ICL Spokesperson ... [email protected] Investor and Press Contact - Global ... VP, ICL Global Investor Relations ... Peggy[email protected] ... [email protected] לארשי - תונותיעו םיעיקשמ ירשק. ויא'גב ידע ICL תרבוד ... ICL Group Ltd.
Edit

Fourth Quarter 2025 Presentation (ICL Group Ltd)

Public Technologies 18 Feb 2026
). 2025 Fourth Quarter. Financial Results. Elad Aharonson . President and CEO February 18, 2026. Strategy alignment . 2025. Profitable Growth. Maximizing Core. Optimization & Efficiency. Specialty Crop Nutrition. Lavie Bio acquisition ... Note ... 3 ... ICL Group Ltd.
Edit

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction (STAAR Surgical Company)

Public Technologies 17 Feb 2026
The approval came shortly after publication of three-year FDA clinical trial safety data, reinforcing the long-term safety profile of the EVO ICL.1 The EVO ICL was previously approved for U.S ... EVO+ Visian ICL Directions for Use.
×